CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −12,207 | $85.02 | $1.0M | 21,628.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −17,143 | $84.59 | $1.5M | 4,485.82 |
| 2024-05-02 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 0 | ||
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −200 | $94.19 | $19K | 33,635.82 |
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −2,712 | $93.72 | $254K | 30,923.82 |
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −9,820 | $91.54 | $899K | 21,103.82 |
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −16,618 | $92.70 | $1.5M | 4,485.82 |
| 2024-04-04 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 29,350 | ||
| 2024-03-04 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-03-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −13,310 | $86.21 | $1.1M | 20,525.82 |
| 2024-03-04 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −16,040 | $87.05 | $1.4M | 4,485.82 |
| 2024-03-04 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 58,700 | ||
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −1,000 | $89.61 | $90K | 32,835.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −6,422 | $88.63 | $569K | 26,413.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −9,761 | $86.44 | $844K | 16,652.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −12,167 | $87.55 | $1.1M | 4,485.82 |
| 2024-02-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 88,050 |
Page 1 of 4 · 66 trades